FSD Pharma Inc. (NASDAQ:HUGE – Get Free Report) was up 4.8% during trading on Monday . The company traded as high as $0.53 and last traded at $0.49. Approximately 675,003 shares were traded during mid-day trading, an increase of 398% from the average daily volume of 135,425 shares. The stock had previously closed at $0.47.
FSD Pharma Trading Down 1.1 %
The business has a 50-day simple moving average of $0.72 and a 200 day simple moving average of $0.91. The stock has a market cap of $18.07 million, a P/E ratio of -0.98 and a beta of 0.59.
FSD Pharma (NASDAQ:HUGE – Get Free Report) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.04) EPS for the quarter.
Institutional Investors Weigh In On FSD Pharma
FSD Pharma Company Profile
FSD Pharma Inc, a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders.
See Also
- Five stocks we like better than FSD Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- High-Yield Texas Instruments Could Hit New Highs Soon
- Do ETFs Pay Dividends? What You Need to Know
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Invest in the Best Canadian Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for FSD Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FSD Pharma and related companies with MarketBeat.com's FREE daily email newsletter.